Keith Henry, MD; Scott Rathgaber, MD; Christopher Sullivan, MD; Kathleen McCabe, RN
Megestrol acetate has been reported to be a relatively nontoxic drug (1, 2) that is efficacious in the treatment of cachexia associated with the acquired immune deficiency syndrome (AIDS) (3). We report the case of a patient with AIDS who developed diabetes mellitus requiring insulin therapy 13 weeks after beginning megestrol therapy and who experienced an exacerbation of his diabetes when rechallenged with megestrol.
A 46-year-old man had been diagnosed with AIDS 2.5 years earlier when a skin biopsy specimen showed Kaposi sarcoma. His treatment regimen is summarized in Figure 1. Before beginning therapy with megestrol acetate, his
Learn more about subscription options.
Register Now for a free account.
Henry K, Rathgaber S, Sullivan C, McCabe K. Diabetes Mellitus Induced by Megestrol Acetate in a Patient with AIDS and Cachexia. Ann Intern Med. 1992;116:53–54. doi: 10.7326/0003-4819-116-1-53
Download citation file:
Published: Ann Intern Med. 1992;116(1):53-54.
HIV, Infectious Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only